Toluca, Mexico

Maria T Lara

This inventor holds 1 USPTO granted patent. Top assignee: Syntex (u.s.a.) Inc.. Active years: 1989.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Maria T Lara. Retrieved from https://idiyas.com/inventor/maria-t-lara

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 1989

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Maria T Lara: Innovator in Prostaglandin Derivatives

Introduction

Maria T Lara is a distinguished inventor based in Toluca, Mexico. She has made significant contributions to the field of pharmaceuticals, particularly in the development of prostaglandin derivatives. Her innovative work has led to the creation of novel compounds that have potential therapeutic applications.

Latest Patents

Maria T Lara holds a patent for "13,14-dihydroprostaglandin C-type derivatives." This patent includes novel 13,14-dihydroprostaglandin derivatives of a specific formula, which are crucial for advancing medical treatments. Her work in this area has garnered attention for its potential impact on health and medicine.

Career Highlights

Maria is associated with Syntex (U.S.A.) Inc., where she has been instrumental in research and development. Her career is marked by a commitment to innovation and excellence in the pharmaceutical industry. With a focus on prostaglandin research, she has contributed to advancements that may improve patient outcomes.

Collaborations

Throughout her career, Maria has collaborated with notable colleagues, including Joan Huguet and Joseph M Muchowski. These partnerships have fostered a collaborative environment that enhances the research and development process.

Conclusion

Maria T Lara's contributions to the field of prostaglandin derivatives exemplify her dedication to innovation in pharmaceuticals. Her work not only highlights her expertise but also underscores the importance of collaboration in scientific advancements.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…